How Carequality navigates a conflict between Epic and Particle Health carries big implications for the future of health data ...

After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.

Opinion: Louisiana’s new restrictions on mifepristone and misoprostol threaten to negate the state’s recent gains in maternal ...

Opinion: Universities can achieve their societal mission to advance knowledge and debate while protecting all voices through ...

U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.

A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...

A major California health insurer is set to offer one of the world’s top-selling drugs for free in a bid to show it can reach ...

The leading CPAP device maker's CEO sees 'two tidal waves' of innovation driving more people to the company's devices.

The connectome could help researchers better understand how to treat diseases like Alzheimer's and Parkinson's.

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...